Literature DB >> 5459472

Effect of phloridzin on uric acid excretion in man.

M D Skeith, L A Healey, R E Cutler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5459472     DOI： 10.1152/ajplegacy.1970.219.4.1080

Source DB:  PubMed          Journal:  Am J Physiol        ISSN： 0002-9513


× No keyword cloud information.
  10 in total

Review 1.  Fructose and uric acid in diabetic nephropathy.

Authors:  Petter Bjornstad; Miguel A Lanaspa; Takuji Ishimoto; Tomoki Kosugi; Shinji Kume; Diana Jalal; David M Maahs; Janet K Snell-Bergeon; Richard J Johnson; Takahiko Nakagawa
Journal:  Diabetologia       Date:  2015-06-07       Impact factor: 10.122

2.  SGLT2 inhibition and renal urate excretion: role of luminal glucose, GLUT9, and URAT1.

Authors:  Aleksandra Novikov; Yiling Fu; Winnie Huang; Brent Freeman; Rohit Patel; Charlotte van Ginkel; Hermann Koepsell; Meinrad Busslinger; Akira Onishi; Josselin Nespoux; Volker Vallon
Journal:  Am J Physiol Renal Physiol       Date:  2018-11-14

Review 3.  Pharmacology of uricosuric drugs.

Authors:  I Kippen; M W Whitehouse; J R Klinenberg
Journal:  Ann Rheum Dis       Date:  1974-07       Impact factor: 19.103

4.  Possible adverse effects of SGLT2 inhibitors on bone.

Authors:  Simeon I Taylor; Jenny E Blau; Kristina I Rother
Journal:  Lancet Diabetes Endocrinol       Date:  2014-12-16       Impact factor: 32.069

5.  Canagliflozin triggers the FGF23/1,25-dihydroxyvitamin D/PTH axis in healthy volunteers in a randomized crossover study.

Authors:  Jenny E Blau; Viviana Bauman; Ellen M Conway; Paolo Piaggi; Mary F Walter; Elizabeth C Wright; Shanna Bernstein; Amber B Courville; Michael T Collins; Kristina I Rother; Simeon I Taylor
Journal:  JCI Insight       Date:  2018-04-19

Review 6.  Tubular effects of sodium-glucose cotransporter 2 inhibitors: intended and unintended consequences.

Authors:  Jessica A Dominguez Rieg; Jianxiang Xue; Timo Rieg
Journal:  Curr Opin Nephrol Hypertens       Date:  2020-09       Impact factor: 2.894

Review 7.  Urate transport in health and disease.

Authors:  Victoria L Halperin Kuhns; Owen M Woodward
Journal:  Best Pract Res Clin Rheumatol       Date:  2021-10-21       Impact factor: 4.098

8.  SGLT2 inhibitor lowers serum uric acid through alteration of uric acid transport activity in renal tubule by increased glycosuria.

Authors:  Yukihiro Chino; Yoshishige Samukawa; Soichi Sakai; Yasuhiro Nakai; Jun-ichi Yamaguchi; Takeo Nakanishi; Ikumi Tamai
Journal:  Biopharm Drug Dispos       Date:  2014-08-06       Impact factor: 1.627

9.  Effect of sodium-glucose cotransporter-2 (SGLT2) inhibitors on serum urate levels in patients with and without diabetes: a systematic review and meta-regression of 43 randomized controlled trials.

Authors:  Alicia Swee Yan Yip; Shariel Leong; Yao Hao Teo; Yao Neng Teo; Nicholas L X Syn; Ray Meng See; Caitlin Fern Wee; Elliot Yeung Chong; Chi-Hang Lee; Mark Y Chan; Tiong-Cheng Yeo; Raymond C C Wong; Ping Chai; Ching-Hui Sia
Journal:  Ther Adv Chronic Dis       Date:  2022-03-23       Impact factor: 5.091

10.  Different Effects of Empagliflozin on Markers of Mineral-Bone Metabolism in Diabetic and Non-Diabetic Patients with Stage 3 Chronic Kidney Disease.

Authors:  Anna Masajtis-Zagajewska; Tomasz Hołub; Katarzyna Pęczek; Agnieszka Makówka; Michał Nowicki
Journal:  Medicina (Kaunas)       Date:  2021-12-11       Impact factor: 2.430
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.